Exercise of Nil Cost Options under PSP

Source: RNS
RNS Number : 2298W
Assura PLC
12 July 2024
 

12 July 2024

Assura plc

("the Company")

Exercise of Nil Cost Options under PSP

Assura plc ("Assura"), the specialist healthcare property investor and developer announces that on 10 July 2024, the PDMRs listed below exercised their 2021 PSP awards.

The table below shows the number of shares vesting, the number of shares sold to satisfy income tax and national insurance liabilities, the number of shares sold for the benefit of the Assura Community Fund and the number of shares received following the sales.


Number of shares awarded

Number of shares sold to satisfy income tax and national insurance liabilities

Additional shares sold on behalf of the Assura Community Fund

Additional shares sold

Number of shares after shares sold

Jonathan Murphy

392,165

184,317

39,217

-

168,631

Jayne Cottam

220,406

103,591

-

-

116,815

Orla Ball

52,903

24,864

-

28,039

-

 

The Remuneration Committee of Assura had agreed that sufficient shares may be sold by each PDMR to cover the arising income tax and national insurance liabilities, that Mr Murphy could sell 39,217 shares to make a contribution to the Assura Community Fund and that Ms Ball could sell the balances of her restricted shares in full. The relevant market price for taxation purposes is £0.4229 per share.

 

As a result of the above, the PDMR's shareholding and those of their connected persons is as follows:


Shareholding on

9 July 2024

 

Shareholding

post exercise

Jonathan Murphy

3,149,294

3,317,925

Jayne Cottam

826,255

943,070

Orla Ball

29,768

29,768

Following the allotment, Mr Murphy & Ms Cottam transferred 168,630 and 116,815 shares respectively to their spouse. The total beneficial holding remains the same.

The Notification of Dealing Forms can be found below.

This notification is made in accordance with the Market Abuse Regulation.

 

Notification of dealing form

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jonathan Murphy

2

Reason for the notification

 

a)

Position/status

 

CEO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Vesting of share awards under PSP

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£NIL GBP

 

392,165

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

N/A

e)

Date of the transaction

 

10/07/2024

f)

Place of the transaction

 

XLON

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Sale of shares to satisfy tax and national insurance liabilities and to make a contribution to the Assura Community Fund.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.4229 GBP

 

223,534

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.4229 GBP

 

 

223,534

 

£94,532.53 GBP

e)

Date of the transaction

 

10/07/2024

f)

Place of the transaction

 

XLON

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Transfer shares to Mr Murphy's spouse

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.4229 GBP

 

168,631

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.4229 GBP

 

 

168,631

 

£71,314.05 GBP

e)

Date of the transaction

 

10/07/2024

f)

Place of the transaction

 

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jayne Cottam

2

Reason for the notification

 

a)

Position/status

 

CFO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Vesting of share awards under PSP

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£NIL GBP

 

220,406

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

N/A

e)

Date of the transaction

 

10/07/2024

f)

Place of the transaction

 

XLON

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Sale of shares to satisfy tax and national insurance liabilities.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.4229 GBP

 

103,591

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.4229 GBP

 

 

103,591

 

£43,808.64 GBP

e)

Date of the transaction

 

10/07/2024

f)

Place of the transaction

 

XLON

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Transfer shares to Ms Cottam's spouse

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.4229 GBP

 

116,815

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.4229 GBP

 

 

116,815

 

£49,401.06 GBP

e)

Date of the transaction

 

10/07/2024

f)

Place of the transaction

 

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Orla Ball

2

Reason for the notification

 

a)

Position/status

 

General Counsel

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Vesting of restricted share awards under PSP

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£NIL GBP

 

52,903

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

N/A

e)

Date of the transaction

 

10/07/2024

f)

Place of the transaction

 

XLON

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Sale of shares to satisfy tax and national insurance liabilities.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.4229 GBP

 

24,864

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.4229 GBP

 

 

24,864

 

£10,514.99 GBP

e)

Date of the transaction

 

10/07/2024

f)

Place of the transaction

 

XLON

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Sale of shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.4229 GBP

 

28,039

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.4229 GBP

 

 

28,039

 

£11,857.69 GBP

e)

Date of the transaction

 

10/07/2024

f)

Place of the transaction

 

XLON

 

- Ends -

For more information, please contact:

 

Assura plc

 

Tel: 0161 515 2043

Orla Ball, General Counsel

David Purcell, Investor Relations Director

 

Email: Investor@assura.co.uk

FGS Global

Gordon Simpson
Grace Whelan

Tel: 0207 251 3801

Email: Assura@fgsglobal.com

 

Notes to Editors

Assura plc is the UK's leading specialist healthcare property investor and developer. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders.

At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPUAUMUPCUBP